SAMIRA ATASHJOO

***** ****** *** **

GERMANTOWN, MD 20874

adj7z8@r.postjobfree.com

301-***-****

EDUCATION

Anticipate, May 2020 Mater in Regulatory Science

University of Maryland Graduate School

August 2016- May 2020 Doctor of Pharmacy Candidate

University of Maryland School of Pharmacy

January 2009 – May 2014 Associate of Science (Pre-Pharmacy)

Montgomery College, MD

CERTIFICATION AND CREDENTIALS

July 2020 Registered Pharmacist, State of Maryland Board of Pharmacy

July 2020 Immunization Certificate, State of Maryland Board of Pharmacy

October 2018 CPR Certification, American Heart Association

October 2018 Immunization Certification, American Pharmacists Association Immunization

Delivery Certification

EXPERIENCE

August 2020 Walgreen Pharmacy; Pharmacist.

Multitasking, handling several tasks such as verification, Transferring Prescription, Transcribed Verbal Prescription, Immunization, Counseling, Ordering medications and supplies, Filling, and dispensing Medications.

February 2017-2020 Giant Pharmacy; Pharmacy Technician. Manager. Dinh Estrade, PharmD

Handling several tasks such as Type Electronic Prescription, Transcribed Verbal Prescription, Transferring Prescription, Filling, and Dispensing Medications.

COMMUNITY & HOSPITAL PHARMACY ROTATION

January-February, 2020 Kaiser Permanente. Preceptor. Yogesh Paruthi, PharmD

Handling several tasks such as Transferring Prescription, Filling, Dispensing Medications, and patient consulting.

February-March, 2010 Adventist Healthcare. Preceptor. Hanieh Afkhami, PharmD

Evaluate laboratory tests to assess medication effectiveness.

Modify, recommend discontinuation or dosage adjustment based on patient lab value and calculated creatinine clearance.

Medication reconciliation and discharge counseling.

Adjust dose of specific drugs such as Warfarin, vancomycin, and Aminoglycosides per Protocol.

November-December, 2019 Adventist Healthcare. Preceptor. Keri Denchfield, PharmD

Participate in multidisciplinary patient care rounds daily basis.

Check reports for antibiotics, IV to PO conversion, and renal dose adjustment; Evaluate laboratory results to recommend dosage or interval adjustment per the Protocol and drug database for renal dysfunction; Evaluate vital signs and WBC counts to recommend IV to PO antibiotic conversion,

Medication reconciliation and patient education.

October-November 2019 Food and Drug Administration (FDA). Preceptor. Sadaf Nabavian, Pharm D

Read FDA Regulatory Affairs Book and Guidance for Industry (Allergic Rhinitis, Chronic Obstructive Pulmonary Disease, and Rheumatoid Arthritis).

Lectured on the rules and responsibilities of Project Manager (RPM).

Read and watch some lectures on OND Prescription Drug Labeling Resources, learn about Selected Requirement Prescribing Information (SRPI) and Labeling Review Process.

Labeling review and comparison of supplemental application includes changes to the label to complete the Selected Requirement of Prescribing Information (SRPI).

Review Request for Breakthrough Therapy Designation to complete Acknowledge-Breakthrough Therapy Request forms.

Attend Advisory Committee meetings, lectures, and minute meetings.

September-October, 2019 Kaiser Permanente. Preceptor. Jamiele Johnson, PharmD

Assess patient’s response to medication, recommend dosage adjustment or class change based on guidelines.

Evaluate laboratory tests to assess medication effectiveness.

Initiate, modify, or discontinue medications for ongoing therapy of chronic disease states such as diabetes, hypertension, hyperlipidemia.

Consult with other healthcare providers about patient treatment needs or options.

Contact patients for medication adherence, concern, and glucometers reading.

July-August 2019 Adventist Healthcare. Preceptor. Gloria Kang, PharmD

Interview patients to complete home medication history, perform medication reconciliation, and provide discharge patient education.

Per Protocol: adjust doses of specific drugs.

Write parenteral nutrition order.

Provide drug recommendation or dosage adjustment in multidisciplinary rounds.

May-June, 2019 Frederick Memorial Hospital. Preceptor. Patricia Grunwald, PharmD

Reading NCCN Guidelines and following patients’ profiles to develop pharmacotherapy knowledge.

Review appropriateness of therapy/specific antineoplastic regimen selected, conduct dosage calculations and recommend dose adjustments based on patient-specific parameters, identify appropriate laboratory tests and clinical assessments used to monitor for drug toxicity and tumor response, monitor for adverse drug reactions, evaluate an emetic potential of specific chemotherapy regimens and assess proper interventions to minimize chemotherapy-induced nausea and vomiting, recognize patients admitted for neutropenic fever and assess antimicrobial therapy to ensure adequate coverage based on patient risk factors.

Participating in “Tumor Board” meetings and attend Paxman Education.

Shadowing Nurse and IV room technician to ensure compliance with USP 797 and 800.

January 2019 Holy Cross Hospital. Preceptor. Lola Gbadamosi, PharmD

Receiving Orders, Storage of Medication in Carousel, Dispensing from Carousel, Fill out Automated Dispensing Cabinet.

Oncology Round and Order Entry

June-July 2018 Giant Pharmacy. Preceptor. Marisa Witkin, PharmD

Received, Transcribed Verbal Prescription, Transferring Prescription, Filling and Dispensing Medications, Counseling Patients, Reviewing Patient Medication Profile for Potential Drug or Disease Interaction, and Providing Over-the-Counter Medication Recommendations.

May 2017 Walgreen Pharmacy. Preceptor. Austin Ladic, PharmD

Filling and Dispensing Medications.

PRESENTATION

March 2020 USP 797 presentation. Present a new version of USP 797.

December 2019 Journal Club. Presentation at Adventist Healthcare cisatracurium vs. usual care

in ARDS (ROSE trial)

October 2019 Patient case presentation. PowerPoint presentation at Kaiser Permanente.

Hot topic presentation, Nourianz package insert. PowerPoint presentation

at Kaiser Permanente (Centralized Teaching Day)

Guidelines presentation (Diabetes, Hypertension, Hyperlipidemia, Asthma).

Presentation at Kaiser Permanente.

August 2019 Patient case presentation. PowerPoint presentation at Adventist Healthcare.

August 2019 Journal Club. Presentation at Adventist Healthcare Avycaz vs. meropenem for

Treatment of pneumonia (REPROVE trial).

June 2019 Chemotherapy-Induced Anemia. PowerPoint Presentation at

JMS Cancer Institute (Frederick Memorial Hospital).

January 2018 Acute Care ISMP Volume 23, issue 25. PowerPoint Presentation at

Holy Cross Hospital.

May 2016 Pharmacist-Managed Weight Management Clinic. PowerPoint Presentation

at the Notre Dame of Maryland School of Pharmacy.

November 2015 Financial Assistant for HIV/AIDS Patients. PowerPoint Presentation at the

Notre Dame of Maryland School of Pharmacy.

December 2015 Hand Washing Project. Poster Presentation at the Sinai Hospital, Engage

Patient/People with Teach-Back Method Under the supervision of Dr. Weber.

RESEARCH

December 2019 cefepime Medication Utilization Evaluation. Adventist HealthCare.

Read Progress-Note of the generated list of patients on cefepime to check if they experienced altered mental status during therapy under the supervision of Critical Care Specialty Pharmacist: Dr. Keri Denchfield

October 2019 Analysis of Covariance for Biologics. Food and Drug Administration (FDA),

Mentor. Ping Ji, PhD

ANOVA vs AVCOVA: generated Excel for all available biologics and biosimilars, used DARRTS, Package Insert, Clinical Pharmacology Biopharmaceutics Reviews(s) (Drugs@FDA), reviewed pharmacokinetics (PK) data, Population PK (PPK) models, PK parameters, Clearance equations and Coefficient for bodyweight to analyze effects of covariance on clearance. This study will be published in the future under an article named “Analysis of covariance with pre-treatment/demographic measurement in parallel clinical pharmacology comparability studies for biologic.”

June 2019 Immune Checkpoint Inhibitors (PD-1/PD-L1) Medication Utilization

Evaluation. JMS Cancer Institute (Frederick Memorial Hospital).

Used Meditech to generate a list of patients on Program Cell Death or

Program Cell Death Ligand 1 inhibitors to evaluate meeting internal and external quality standards.

January-May, 2019 Opioid Overdose Pattern in Maryland.

Health Policy and Management Practicum, University of Maryland School of Pharmacy.

Assessment and comparison of prevalence, incident, and impact of opioid overdose in Maryland and the United States.

January 2019 IV Iron Medication Utilization Evaluation. Holy Cross Hospital.

Iron dextrose was displaced by Sodium ferric gluconate at Holy Cross Hospital in 2016. I generated a list of patients who have received Sodium ferric gluconate to analyze the appropriateness of use based on the Protocol under the supervision of Specialty Pharmacist:

Dr. Sheheryar Muhammad

January 2019 Heparin Drip Tracer Analysis. Holy Cross Hospital.

Used medmined surveillance to generate a list of patients on Heparin; only patients on IV Heparin Drip were included. I had analyzed the appropriate bolus dose, infusion rate, monitoring, and therapeutic aPTT under the supervision of Dr. Linda McKee

COMMUNITY SERVICES

January 2019 Maryland Responds Medical Reserve Corps, Volunteer

February 2016 Legislative Day.

August 2015 Arc Baltimore. Volunteer

A public health initiative is serving, children who have autism, vulnerable populations through education and healthcare activities.

PROFESSIONAL ORGANIZATION

Pediatric Pharmacy Advocacy Group (PPAG), member

American Society of Hospital Pharmacy (ASHP), member

HONORS AND AWARDS

2009-2019 Dean’s list

Contact this candidate